{"id":"W2158179945","doi":"10.1016/s1470-2045(03)01137-9","title":"Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer","year":2003,"lang":"en","type":"review","venue":"The Lancet Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network; University of Toronto","funders":"Cancer Research Society; American Association for Cancer Research","keywords":"Erlotinib; Gefitinib; Cetuximab; Epidermal growth factor receptor; Medicine; Lung cancer; Amphiregulin; Cancer research; Epidermal growth factor; Tyrosine kinase; Cancer; Carcinogenesis; Trastuzumab; Oncology; Receptor; Internal medicine; Colorectal cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01514349,0.0006008121,0.00895162,0.0004333087,0.00008685899,0.000009156713,0.00122282,0.0009977088,0.001272511],"category_scores_gemma":[0.002829869,0.0003285006,0.0008824637,0.001758713,0.001255606,0.00003049427,0.0003149608,0.004996294,0.00009774208],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001144092,"about_ca_system_score_gemma":0.01195771,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005597971,"about_ca_topic_score_gemma":0.0001393926,"domain_scores_codex":[0.9857845,0.007721724,0.002814233,0.0009705826,0.001462743,0.00124616],"domain_scores_gemma":[0.9877647,0.006816526,0.001685689,0.002020697,0.001328739,0.0003836151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005493076,0.000577866,0.0009038722,0.325519,0.0005920468,0.0001074806,0.0001100194,1.225198e-7,0.000002208888,0.00009181129,0.1615595,0.5099868],"study_design_scores_gemma":[0.001717922,0.003195959,0.00003338765,0.2231989,0.000964565,0.0000662009,0.00001892298,0.000001100088,0.00005987833,0.00001539538,0.7705081,0.0002196572],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001363858,0.9621376,0.000003794673,0.004740069,0.0007569811,0.00595047,0.0001297457,0.0000251717,0.02611972],"genre_scores_gemma":[0.00004236251,0.9928949,0.0005066438,0.0009603435,0.002419663,0.001492574,0.0000289935,0.0001614794,0.001493064],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6089486,"threshold_uncertainty_score":0.9999167,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3917200543381659,"score_gpt":0.5739504872546254,"score_spread":0.1822304329164595,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}